10x Genomics
TXG
51.80
-5.58
-9.72%
10x Genomics
US · TXG
#1311 by market cap
Listed 2019
51.80
-5.58
-9.72%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
About 10x Genomics
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
- Founded
- 2012
- CEO
- Dr. Serge Saxonov, PhD
- Employees
- 1,178
- Headquarters
- Pleasanton, California, United States of America
- Fiscal year end
- 12-31
- Website
- 10xgenomics.com
Company profile
- Exchange
- US
- Symbol
- TXG
- Market-cap rank
- #1311
- Listing date
- 2019-09-12
- Market cap
- 6.81B
- Float cap
- 6.19B
- Shares out
- 131.53M
- Float shares
- 119.47M
Sectors & themes
Quote time 2026-11-20 20:02:38 · For reference only, not investment advice and not tailored to your situation.
10x Genomics discussion 0 comments